| Name: Update on Epidemiology and Therapeutics for Non-Hodgkin's Lymphoma -- Vose et al. 2002 (1): 241 -- Hematology
Description: 1999estimated from the SurveillanceEpidemiologyand End Results (SEER) Program rapamycin were infectionmyelosuppressionand hyperlipidemiathough these were infrequent.
Category: Epidemiology Hyperlipidemia
Url: http://www.asheducationbook.org/cgi/content/full/2002/1/241
Date: Oct 7, 2005
Current Rating: 0.00
Clicks/Hits Received: 0 |
|